← Search & browse all drugs
DERMATOLOGICALS › OTHER DERMATOLOGICAL PREPARATIONS › OTHER DERMATOLOGICAL PREPARATIONS › Androgens for topical use
metandienone
D11AE01
Forms & Strengths
- Tablets: 2.5mg, 5mg
- Injectable: 25mg/mL, 50mg/mL
Adult Dosing
- 2.5-5mg orally, 2-3 times a day
- 25-50mg intramuscularly, every 2-3 weeks
Pediatric Dosing
- Not recommended for use in pediatric patients under 18 years of age
Indications
- Replacement therapy in conditions associated with severe hormone deficiency
- Applastic anemia
Mechanism of Action
- Stimulates protein synthesis and muscle growth
- Inhibits glucocorticoid hormone production
Contraindications
- Hypersensitivity to metandienone or any component of the formulation
- Prostate cancer
- Breast cancer
- Pregnancy and lactation
Adverse Reactions
- Acne
- Hirsutism
- Gynecomastia
- Liver dysfunction
- Fluid retention
- Aggression
Drug Interactions
- Warfarin: increased anticoagulant effect
- Insulin and oral hypoglycemics: increased risk of hypoglycemia
Curated Content: Needs Vetting Before Put to Clinical Use